Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.
Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.2%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference3%
- Check36 days agoChange DetectedSeveral key health-related resources and disease information pages have been removed, including links to lymphoma and rare disease information, as well as clinical trial documents.SummaryDifference0.6%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added related to lymphoma and clinical trials, including links to MedlinePlus and DailyMed for drug information.SummaryDifference3%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.